Reuters logo
BRIEF-Expres2ion and NextGen enter a joint venture
June 21, 2017 / 2:02 PM / 3 months ago

BRIEF-Expres2ion and NextGen enter a joint venture

June 21 (Reuters) - EXPRES2ION BIOTECH HOLDING AB

* EXPRES2ION AND NEXTGEN ENTER A JOINT VENTURE FOR ACCELERATED DEVELOPMENT OF NEW, IMPROVED VACCINES AND IMMUNE THERAPY

* FULLY OWNED SUBSIDIARY EXPRES2ION BIOTECHNOLOGIES APS (“EXPRES2ION”) HAS ESTABLISHED A JOINT VENTURE NAMED ADAPTVAC APS WITH NEXTGEN VACCINES APS (“NEXTGEN”) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below